Kuhns v. Teva Pharmaceuticals USA, Inc. et al
| April Kuhns |
| Teva Pharmaceuticals USA, Inc., Teva Women's Health, LLC, Teva Branded Pharmaceutical Products R&D, Inc., The Cooper Companies, Inc. and CooperSurgical, Inc. |
| 1:2023cv05801 |
| December 15, 2023 |
| US District Court for the Northern District of Georgia |
| Leigh Martin May |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. ยง 1332 Diversity-Product Liability |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on December 26, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 3 WAIVER OF SERVICE Returned Executed by April Kuhns. CooperSurgical, Inc. waiver mailed on 12/20/2023, answer due 2/20/2024; Teva Branded Pharmaceutical Products R&D, Inc. waiver mailed on 12/20/2023, answer due 2/20/2024; Teva Pharmaceuticals USA, Inc. waiver mailed on 12/20/2023, answer due 2/20/2024; Teva Women's Health, LLC waiver mailed on 12/20/2023, answer due 2/20/2024; The Cooper Companies, Inc. waiver mailed on 12/20/2023, answer due 2/20/2024. (Attachments: #1 Exhibit A - Waivers of Service of Summons)(Feller, Christina) |
| Remark: Counsel should review all Orders docketed in MDL Case No. 1:20-md-2974-LMM. The Court's Case Management Orders and other case-related documents can also be found on the Court's MDL web page: https://www.gand.uscourts.gov/20md2974(bnp) (bnp) |
Filing 2
ORDER INITIAL CONFERENCE: The Court held its Initial Conference in this MDL on February 9, 2021. Thebelow are the orders entered after discussion of these issues at that conference. 1. Leadershipstructure: After the Court discussed issues concerning the leadership structure with all parties, the CourtORDERED Plaintiffs and Defendants to each file their proposed consent motion and order as to theirrequested leadership structure and team within 7 days of the date of this order. 2. Future statusconferences: The Court will hold status conferences once a month. The next six conferences will takeplace on the following dates at 10:00 am via zoom: Tuesday, March 9, 2021; Monday, April 12, 2021;Wednesday, May 12, 2021; Monday, June 14, 2021; Tuesday, July 13, 2021; Friday, August 20, 2021. TheCourt will send out the zoom links prior to the conferences. The parties will submit a proposed consentagenda 3 business days prior to the conference. The parties will also confer as to the format forpresenting issues that require additional explanation. When these are necessary, they should also befiled 3 business days before the conference. 3. Stay of responsive pleading obligations: The Courtcontinues the stay of responsive pleading obligations provided for in Section 6(b) of the Court's initialorder. 4. Pending motions: The Court DENIES WITHOUT PREJUDICE all pending motions in the individualcases comprising the MDL. These cases are also ADMINISTRATIVELY CLOSED. These terminated motionswill later be refiled in accordance with an upcoming Case Management Order. 5. Docketing: All partiesare to docket future filings only in the MDL case. The case caption should indicate whether any filingapplies to all cases or list the individual cases to which it should apply. 6. Electronic service: The CourtORDERS all attorneys participating in the MDL proceeding to register with the Court's CM/ECF system.Because all attorneys will then receive electronic copies of documents filed in the MDL, the CourtORDERS that electronic service of documents via the Court's CM/ECF system satisfies the obligation ofservice. Hereafter, unless otherwise ordered, neither the clerk's office nor counsel for the parties shallbe obligated to provide service copies of any filings or related orders by U.S. Mail or any other means toattorneys who have not registered with the Court's CM/ECF system. An attorney who is not participatingin the MDL and does not want to receive CM/ECF notifications may file a motion to withdraw or acertificate of consent to withdraw in accordance with Local Rule 83.1(E). 7. Initial disclosures: The CourtGRANTS the parties' joint request for the Court to excuse the parties from Rule 26(f) initial disclosures;except as to the ParaGard New Drug Application (NDA) that was transferred on or about November 10,2005, to Duramed Pharmaceuticals, Inc., and produced by TWH, Inc., to plaintiff in the Estrada case. 8.Case management and initial orders: The parties are ORDERED to confer as to proposed orders for thelist found herein. See order for further specifics and instructions. Signed by Judge Leigh Martin May on 02/10/2021. (jkb)
|
| Filing 1 SHORT FORM COMPLAINT with Jury Demand filed by April Kuhns. (Filing fee $405, receipt number AGANDC-13102151) (Attachments: #1 Civil Cover Sheet)(jkb) Please visit our website at http://www.gand.uscourts.gov/commonly-used-forms to obtain Pretrial Instructions and Pretrial Associated Forms which includes the Consent To Proceed Before U.S. Magistrate form. Modified on 12/18/2023 (jkb). |
| Civil Case Terminated. (jkb) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Georgia Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
